Showing posts with label Patent. Show all posts
Showing posts with label Patent. Show all posts

Tuesday, October 15, 2013

Designer Babies and Other Patented Life Forms

Wooden Sculpture of Science Genetics
Wooden Sculpture of Science Genetics (Photo credit: epSos.de)
By Dr. Mercola
In 2001, a study1 announcing the successful birth of the world’s first genetically engineered babies—30 in total—was published. This staggering development didn’t receive media attention until nearly a decade later.
The children were created using genes from TWO women and one man—a process referred to as ooplasmic transplantation, in which genes from a female donor are inserted into another woman’s eggs before being fertilized with a man’s sperm.
What the ramifications of having the genetic traits of three parents might be for the individual, or for their subsequent offspring, is still unknown.
However, based on what I’ve learned about the genetic engineering of plants, I’m inclined to say the consequences could be vast, dire, and most likely completely unexpected.
In fact, it only took two years for follow-up reports to begin discussing problems encountered in these genetically engineered babies. According to one such report:2
“A frank follow-up of ooplasmic transplantation pregnancies and infants reports that two out of 17 fetuses had an abnormal 45, XO karyotype. The authors assume the hypothesis of a link between chromosomal anomalies and oocytes manipulation, and reveal that one of the babies has been diagnosed at 18 months with Pervasive Developmental Disorder, a spectrum of autism-related diagnoses."
Despite such risks, and the lack of public discussion about these kinds of ventures, genetic scientists are steadily forging ahead, bringing us ever closer to the reality of “designer babies”—children born with traits predetermined by the parents’ choice.
As a matter of fact, the genetic modification of humans appears to have been running alongside the genetic engineering of plants, being just a few years behind in terms of the technology being unleashed. The lack of proper evaluation of health effects is apparently on par as well, which is to say near non-existent.

Are 'Design-A-Baby' Centers Next?

As recently reported by BBC News,3 a US patent has been filed for a DNA testing database, which would be used by prospective parents to find out which traits their future offspring might inherit. Critics call it “ethically and socially treacherous,” and I’m inclined to agree. According to the featured article:
“23andMe says its Family Traits Inheritor Calculator can predict the risk of inheriting specific diseases as well as details such as height, weight, eye color and even personality. Couples send the firm a saliva sample to see what their babies might be like.
... But critics remain concerned that such technology could be misused. 'It would be highly irresponsible for 23andMe or anyone else to offer a product or service based on this patent,' said Marcy Darnovsky, executive director of the Center for Genetics and Society... We believe the patent office made a serious mistake in allowing a patent that includes drop-down menus for which to choose a future child's traits.’”

Could Humans Eventually Become Patented Property?

One nightmarish scenario humanity might be faced with, should genetic engineering and designing of humans continue unchecked, is the potential for a patent war; meaning these genetically engineered humans could become patentable property.
Sound crazy?
You bet! But it’s not outside the realm of possibility. The world is already embroiled in discussions about which genetically engineered life forms can and cannot be patented,4 and biotech companies have secured patents on everything from genetically modified seeds to engineered animals of various kinds.
Furthermore, as of 2005, nearly 20 percent of human genes were already patented,5 and are explicitly claimed as intellectual property by one company or another. Unchallenged, what’s to stop a company from eventually claiming patent rights on an entire individual?
In an effort to put the brakes on this disturbing trend, the American Civil Liberties Union (ACLU)6 has sued the US Patent and Trademark Office to stop the practice of issuing patents that are contrary to the law—which states that only inventionscan be patented; not naturally-occurring parts of the human body. As explained by the ACLU:7
“For example, Myriad Genetics, a private biotechnology company based in Utah, controls patents on the BRCA1 and BRCA2 genes [two genes associated with hereditary breast and ovarian cancer]. Because of its patents, Myriad has the right to prevent anyone else from testing, studying, or even looking at these genes. It also holds the exclusive rights to any mutations along those genes. No one is allowed to do anything with the BRCA genes without Myriad's permission.”
Thankfully, on June 13 this year, the US Supreme Court unanimously invalidated the patents on BRCA 1 and BRCA 2—an important victory in the fight to reclaim our genes.8 But we still have a long way to go. Patenting of seeds, for example, is just as hazardous to the future of mankind as the patenting of human genes.

One Human, Multiple Genomes

Genetic research is of course important, and has revealed some very interesting misconceptions. Unfortunately, many scientists fail to take such findings into account. One example is the genetic engineering of plants, which are considered to be “equivalent” to conventional varieties even though there are in fact vast differences.

For example, genetically engineered plants typically end up producing novel proteins that have never existed in the food supply before, courtesy of the new genetic material that has been inserted.
The increased use of GE crops in the American food supply is one explanation for the dramatic uptick in food allergies and gastrointestinal problems over the past two decades.
The Human Genome Project, which was completed in 2003, discovered that we have nowhere near enough genes to account for all the biological functions in the human body, and the reason for this is because genes do not operate as previously predicted. In a nutshell, having a "cancer program" in your DNA does not automatically mean you're destined to get cancer. Far from it, because simply having the genetic information does not mean it will be expressed.
As it turns out, any given gene can create and encode tens of thousands of different proteins, and it is these proteins that dictate cell function. What’s most important here is that the types of proteins encoded is dependent on the environment in which the cell finds itself.

In fact, the epigenetic influences appear to be most powerful. These are the factors that cause your genes to actually be expressed and produce the proteins they encode for. A toxic environment will cause a gene to produce different proteins than a non-toxic environment for example.
That said, according to more recent research,9 the picture is likely even more complex. Researchers have now discovered that while each person has one major genome, on the cellular level you can have multiple different genomes, depending on the tissue. As stated in a recent Science Magazine interview with the author of the study, James Lupski:10, 11
“[R]esearchers have come to realize that we are made up of a mosaic of cells—populations of cells with different versions of the genome, present in varying degrees in different tissues.

A few base pair changes, a few extra copies of a repetitive sequence—these things seem small on the scale of three billion base pairs, but it does mean that there is no ‘true you’ spelled out in your genes, and it also means that these slight differences could impact development and health...
 ‘So certainly, if you’re looking at the blood, it doesn’t tell you what’s going on in the brain,’ [says James Lupski].
Interestingly enough, genome mosaicism does not necessarily equate to disease. In fact, in his paper12 Lupski states that mosaicism has also been found in healthy tissues, and may even play a role in the normal functioning of cells. Mosaicism also comes into play when you’re talking about hereditary diseases, which makes the idea of creating “designer babies” all the more daunting and fraught with unforeseen risks. In his paper, Lupski writes:
“Mosaicism and risk for recurrence in offspring may also relate to the time in embryo-genesis at which the de novo mutational event occurred. If the parent is germline mosaic, he or she is at risk for a recurrence of another child with the disease.
...From a diagnostics standpoint, it is important to realize that genome analyses reflect the average genome of the cells one examines. Thus, for chorionic villus sampling, an abnormality observed may represent confined placental mosaicism. When performing karyotype analysis from a blood sample, only cells stimulated to grow are assayed for chromosomes, whereas total DNA isolated from white blood cells comes from more cell types and thus may detect mosaicism. However, none of these approaches informs on the presence of mosaicism in the brain or other tissues and organs.”

Your Genes Do Not Predetermine Your Health

The major problem with believing the myth that your genes control your life is that you become a victim of your heredity. Since you can't change your genes, it essentially means that your life is predetermined, and therefore you have very little control over your health. Quelling such fears is what “designer babies” is all about—the idea that you can safeguard your offspring from certain health risks. (Of course, taken to an extreme, such fantasies also include the ability to design a child that has specifically chosen physical and mental characteristics, and perhaps even specific personality traits.)
But the new science, oftentimes referred to as epigenetics, reveals that you are in fact an extension of your environment, which includes everything from your thoughts and belief systems, to toxic exposures and exposure to sunlight, exercise, and, of course, everything you choose to put onto and into your body.
Rather than looking for a way to “design” healthier humans through genetic manipulation, it would make far more sense to address our environment, including our food supply, instead—so that everyone, whether we’re “custom made” or not, can thrive and be the healthiest version of ourselves that we can be.
Science has now taken us far beyond Newtonian physics, which says you live in a mechanical universe. Your body is NOT just a biological machine whose health can be modified by altering the parts of the machine. Unfortunately, conventional science is being slow on the uptake of these facts, and the entire pharmaceutical paradigm is still rooted in the Newtonian view of the body as a biological machine. As such, your body is thought to respond to physical "things" like the active chemicals in drugs, and by adjusting the drugs that modify your machinery, doctors can modify and control health.
However, as biophysics and quantum physics shows us that the invisible, immaterial realm is actually far more important than the material realm, so your immaterial thoughts may actually shape your biological environment and genetic expression to a greater degree than a drug...
Unfortunately, as a general broad-strokes rule, it seems few scientists fond of gene-tinkering have a well-rounded or holistic view of living organisms, opting instead to view the human body as a machine. And as demonstrated with the multi-varied problems that have arisen from genetically engineered foods—from the development of superweeds and superpests, to the creation of anever-before-seen organism now linked to miscarriage and infertility—such a view is bound to lead you to the wrong conclusions.

Patenting of Seeds Threaten Biodiversity and the Future of Mankind

Over the past 18 years or so, a collection of five giant biotech and chemical corporations -- Monsanto, Syngenta, Bayer, Dow and DuPont -- have bought up more than 200 other companies, allowing them to dominate access to seeds. The enormous ramifications of this should be fairly obvious.
For starters, the takeover has been so dramatic that it’s difficult for farmers to find alternatives. As a result, 90 percent of soybeans grown in the US are genetically engineered, and many conventional farmers have trouble obtaining non-genetically modified seeds. Genetically engineered (GE) seeds, particularly corn and soy, have now taken over in many areas of the world, effectively eliminating the use of conventional and "heirloom" seeds, and along with them, the ancient, sustainable farming practices that produces healthful food.
What’s worse, besides patenting their own GE seeds, Monsanto has also succeeded in slapping patents on a large number of common crop seeds, in essence patenting life forms for the first time -- without a single vote of the people or Congress. By doing this, Monsanto has become the sole owner of many of the very seeds necessary to support the world's food supply… an incredibly powerful position for any company to be in.
One solution to this growing problem would be to make patenting seeds, plants, and genes illegal. As it stands now, each genetically engineered seed is patented and sold under exclusive rights. Therefore, farmers must purchase the GE seeds anew each year, because saving seeds is considered to be patent infringement. Anyone who does save GE seeds must pay a license fee to actually re-sow them. This, of course, results in higher prices and reduced product options.
Add in the increased need for pesticides and herbicides like Roundup that GE crops require, and the ever rising cost of these products, and what you end up with is a far more expensive crop that has the potential to not only fail more frequently than conventional crops, but that can also be extremely harmful to the animals and humans who eat them.

Even the NY Times Is Becoming Concerned About Monsanto

I’ve written extensively about the health hazards and environmental harm caused by glyphosate, the active ingredient in Monsanto’s herbicide Roundup. The New York Times13 also recently addressed the issue:
“‘Because glyphosate moves into the soil from the plant, it seems to affect the rhizosphere, the ecology around the root zone, which in turn can affect plant health,’ said Robert Kremer, a scientist at the United States Agriculture Department, who has studied the impact of glyphosate on soybeans for more than a decade and has warned of the herbicide’s impact on soil health. Like the human microbiome, the plants’ roots systems rely on a complex system of bacteria, fungi and minerals in the soil. The combination, in the right balance, helps protect the crops from diseases and improves photosynthesis.
In some studies, scientists have found that a big selling point for the pesticide — that it binds tightly to minerals in the soil, like calcium, boron and manganese, thus preventing runoff — also means it competes with plants for those nutrients. Other research indicates that glyphosate can alter the mix of bacteria and fungi that interact with plant root systems, making them more susceptible to parasites and pathogens.”

Other Life Forms Potentially Slated for Patenting: Soil Microbes

Incredibly, the NY Times article also actually hints at the possibility of engineering soil microbes to “make up” for the detrimental effects of Roundup! Earlier this year, Monsanto purchased “select assets” of Agradis,14 a “sustainable agricultural solutions” company founded by J. Craig Venter, a scientist who sequenced the human genome to develop various microbes and “agricultural biologicals.” Monsanto also acquired a collection of Venter’s microbes.
According to Monsanto’s chief technology officer Robert Fraley, “the foray into microbes... is to improve yield and address some of the issues raised about glyphosate.” What the future might hold if they actually go so far as to tinker with genetically engineered soil microbes is anyone’s guess. But I’m betting it won’t be good.

Why GMO Labeling Is a Must

All in all, it should be quite clear that mankind has ventured into some very deep waters in our quest to master nature. As a result, private companies have laid claim to numerous life forms from various kingdoms, including human genes. Unless this trend is halted, we may end up with a world in which corporate entities own quite literally everything—from soil microbes to individual humans. It sounds inconceivable, and yet this is the reality we’re already in; it’s just a matter of degree, really.
While the obstacles may appear near-insurmountable, I urge you to not fall into despair, but rather to join forces with those who are actively working to protect life, in all its forms, from corporate takeover. There are many such organizations and projects. At this very moment, I would encourage you to engage in the efforts to get genetically engineered foods labeled in the US.
This is an absolutely crucial component of reining in the corporate takeover of agriculture. Without labels, you cannot know what you’re buying. And unless consumer demand calls for other types of foods besides genetically engineered varieties, farmers do not have any incentive to plant them since so few food companies currently buy non-GE crops. This issue will become even more important once genetically engineered food animals are introduced. So please, support the efforts to get genetically modified organisms (GMOs) labeled.

Join Us in Your Right to Know by Getting GMOs Labeled!

While California Prop. 37 failed to pass last November by a very narrow margin, the fight for GMO labeling is far from over. In the past few weeks, Connecticut and Maine have passed GMO-labeling bills, and 20 other states have pending legislation to label genetically engineered foods. So, now is the time to put the pedal to the metal and get labeling across the country—something 64 other countries already have.
I hope you will join us in this effort.
The field-of-play has now moved to the state of Washington, where the people's initiative 522, "The People's Right to Know Genetically Engineered Food Act," will require food sold in retail outlets to be labeled if it contains genetically engineered ingredients. Please help us win this key GMO labeling battle and continue to build momentum for GMO labeling in other states by making a donation to the Organic Consumers Association (OCA).

 Remember, as with CA Prop. 37, they need support of people like YOU to succeed. Prop. 37 failed with a very narrow margin simply because we didn't have the funds to counter the massive ad campaigns created by the No on 37 camp, led by Monsanto and other major food companies. Let's not allow Monsanto and its allies to confuse and mislead the people of Washington and Vermont as they did in California. So please, I urge you to get involved and help in any way you can.
  • No matter where you live in the United States, please donate money to these labeling efforts through the Organic Consumers Fund.
  • Sign up to learn more about how you can get involved by visiting Yeson522.com!
  • For timely updates on issues relating to these and other labeling initiatives, please join the Organic Consumers Association on Facebook, or follow them on Twitter.
  • Talk to organic producers and stores and ask them to actively support the Washington initiative.
Enhanced by Zemanta

Monday, June 24, 2013

A History of Patenting Medicine - The Granting of Monopolies

English: United States Patent Cover from a rea...
English: United States Patent Cover from a real patent issued (Photo credit: Wikipedia)
The following is a brief excerpt from "Old English Patent Medicines in America", written about 100 years ago. It's an interesting view of history and how patents have changed the world and where it all came from.

_Bateman's Pectoral Drops, Godfrey's Cordial, Turlington's Balsam of
Life, Hooper's Female Pills, and a half-dozen other similar nostrums
originated in England, mostly during the first half of the 18th
century. Advertised with extravagant claims, their use soon spread to
the American Colonies._
_To the busy settler, with little time and small means, these
ready-made and comparatively inexpensive "remedies" appealed as a
solution to problems of medical and pharmaceutical aid. Their
popularity brought forth a host of American imitations and made an
impression not soon forgotten or discarded._

In 1726 King George I granted a patent for the making and selling of
Dr. Bateman's Pectoral Drops. The patent was given not to a doctor, but
to a business man named Benjamin Okell. In the words of the patent,[3]
Okell is lauded for having "found out and brought to Perfection, a new
Chymicall Preparacion and Medicine..., working chiefly by Moderate
Sweat and Urine, exceeding all other Medicines yet found out for the
Rheumatism, which is highly useful under the Afflictions of the Stone,
Gravell, Pains, Agues, and Hysterias...." What the chemicals
constituting his remedy were, the patentee did not vouchsafe to reveal.
[3] Benjamin Okell, "Pectoral drops for rheumatism, gravel,
etc.," British patent 483, March 31, 1726.


The practice of patenting had begun in royal prerogative. Long
accustomed to granting monopoly privileges for the development of new
industries, the discovery of new lands, and the enrichment of court
favorites, various monarchs in 17th-century Europe had given letters
patent to proprietors of medical remedies which had gained popular
acclaim. In France and the German States, this practice continued well
through the 18th century. In England, where representative government
had progressed at the expense of the personal prerogative of the
sovereign, Parliament passed a law in 1624 aimed at curbing arbitrary
actions like those of James I and Charles I. The statute declared all
monopolies void except those extended to the first inventor of a new
process of manufacture. To such pioneers the king could grant his
letters patent bestowing monopoly privileges for a period of 14 years.
That the machinery set up by this law did not completely curb the
independence of English sovereigns in the medical realm is indicated by
the favor extended Dr. Weir, who successfully sought from James II a
privileged position for Anderson's Scots Pills. This kingly grant is
not included in the regular list, and the Glorious Revolution of 1688
brought an end to such an exercise of royal power without consent of
Parliament. A list of patents in the medical field later published by
the Commissioners of Patents[4] includes only six issued during the
17th century, four for baths and devices, one for an improved method of
preparing alum, and one for making epsom salts. The first patent for a
compound medicine was granted in 1711, and only two other proprietors
preceded Benjamin Okell in seeking this particular legal form of
protection and promotion.


As early as 1721, Bateman's Pectoral Drops were being regularly
advertised in the _London Mercury_. The advertisements announced: "Dr.
Bateman's Pectoral DROPS published at the Request of several Persons of
Distinction from both Universities...." The Drops, priced at "1 s. a
Bottle," were "Sold Wholesale and Retail at the Printing-house and
Picture Warehouse in Bow Churchyard," and likewise "in most Cities and
celebrated Towns in Great Britain." "Each Bottle Seal'd with the Boar's
Head." So stated the advertisement, which itself contained a crude cut
of this Boar's Head seal.[5] Elsewhere in this issue of the _Mercury_,
we learn that John Cluer, printer, was the proprietor of the Bow
Churchyard Warehouse. This same John Cluer, along with William Dicey
and Robert Raikes, were named in the 1726 patent as "the Persons
concerned with the said Inventor," Benjamin Okell, who, with him,
should "enjoy the sole Benefit of the said Medicine." It was this
partnership which was to find the field of nostrum promotion especially
congenial and which was to play an important transatlantic role. Soon
after securing their patent, the proprietors undertook to inform their
countrymen about the remedy by issuing _A short treatise of the virtues
of Dr. Bateman's Pectoral Drops_.[6]

[4] British Patent Office, _Patents for inventions: abridgements
of specifications relating to medicine, surgery, and dentistry,
1620-1866_, London, 1872.
[5] _London Mercury_, London, August 19-26, 1721.
[6] _A short treatise of the virtues of Dr. Bateman's Pectoral
Drops_, New York, 1731. A 36-page pamphlet preserved in the
Library of the New York Academy of Medicine. This is an American
reprint of an English original, date unknown.


It was the 18th century, and the essay was in fashion. The proprietors
prepared a didactic introduction to their treatise, phrased in long and
flowery sentences, in which modesty was not the governing tone. The
arguments ran like this: that the "Universal Good of Mankind" should be
the aim of "every private member"; that nothing is so conducive to this
general welfare as "HEALTH"; that no hazards to health are more direful
than diseases such as "the Gout; the Rheumatism; the Stone; the
Jaundice," etc., etc.; that countless men and women have succumbed to
such afflictions either because they received no treatment or suffered
wrong treatment at "the Hands of the Learned"; that no medicine is so
sure a cure as that inexpensive remedy discovered as a result of great
"Piety, Learning and Industry" by one "inspir'd with the Love of his
Country, and the Good of Mankind," to wit. "Dr. BATEMAN'S Pectoral
Drops."

Then followed seven chapters treating the multitude of illnesses for
which the Drops were a specific. Finally, the pamphlet cited "some few,
out of the many thousands of Certificates of Cures effected by these
DROPS...." Even so early was the testimonial deemed a powerful
persuader.

No more could Okell, Cluer, Dicey, and Raikes escape competition than
could the proprietors of other successful nostrums. In 1755 they went
to court and won a suit for the infringement of their patent, but the
damages amounted to only a shilling. Even after the patent expired, the
tide of publicity flowed on.[7]

[7] A broadside, issued in London, _ca._ 1750, advertising "Dr.
Bateman's Drops," is preserved in the Warshaw Collection of
Business Americana, New York. Later reprints of this same
broadside are preserved in the private collection of Samuel Aker,
Albany, New York, and in the Smithsonian Institution.

Competition was also lively in the 1740's among some half a dozen
proprietors marketing a form of crude petroleum under the name of
British Oil. Early in the decade Michael and Thomas Betton were granted
a patent for "An Oyl extracted from a Flinty Rock for the Cure of
Rheumatick and Scorbutick and other Cases." The source of the oil,
according to their specifications, was rock lying just above the coal
in mines, and this rock was pulverized and heated in a furnace to
extract all the precious healing oil.[8] This Betton patent aroused one
of their rivals, Edmund Darby & Co. of Coalbrook-Dale in Shropshire.
Darby asserted that it was presumptuous of the Bettons to call their
British oyl a new invention.[9] For over a century Darby and his
predecessors had been marketing this self-same product, and it had
proved to be "the one and only unrivall'd and most efficacious Remedy
ever yet discovered, against the whole force of Diseases and Accidents
that await Mankind...." For the Bettons to appropriate the process and
patent it--and even to claim in their advertising cures which really
had been wrought by the Darby product--was scandalous. Worse than that,
said Darby, it was illegal, for in 1693 William III had granted a
patent to "Martin Eele and two others at his Nomination for making the
same Sort of Oyl from the same Sort of Materials."

 Evidence to
substantiate his belief in the Betton perfidy was presented by Darby to
George II, who had the matter duly investigated.[10] Being persuaded
that Darby was right, the king and his councillors, in 1745, vacated
the Betton patent. This victory seems not to have boomed the Darby
interests, and this defeat seems not to have ruined the Bettons. During
the succeeding century, the Betton patent was published and republished
in advertising, just as if it had never fallen afoul the law. From
their battles with the Oil from Coalbrook-Dale and other British Oils
marketed by other proprietors, the Bettons emerged triumphant. In the
years to come, patent or no, the Bettons British Oil was to dominate
the field.

[8] Michael and Thomas Betton, "Oil for the cure of rheumatic and
scorbutic affections," British patent 587, August 14, 1742.
[9] Edmund Darby & Co., _Directions for taking inwardly and using
outwardly the company's true genuine and original British Oil;
prepared by Edmund Darby & Co. at Coalbrook-Dale, Shropshire_,
ca. 1745. An 8-page pamphlet preserved in the Library of the
College of Physicians, Philadelphia, Pennsylvania.
[10] _London Gazette_, London, March 1, 1745.

The year after the Bettons had secured their patent, another was
granted to John Hooper of Reading for the manufacture of "Female Pills"
bearing his name.[11] Hooper was an apothecary, a man-midwife, and a
shrewd fellow. This was the period in which the British Government was
increasing its efforts to require the patentee to furnish precise
specifications with his application.[12] When Hooper was called upon to
tell what was in his pills and how they were made, he replied by
asserting that they were composed "Of the best purging stomatick and
anti-hysterick ingredients," which were formed into pills the size of a
small pea. This satisfied the royal agents and Hooper went on about his
business. In an advertisement of the same year, he was able to cite as
a witness to his patent the name of the Archbishop of Canterbury.[13]

[11] John Hooper, "Pills," British patent 592, July 21, 1743.
[12] E. Burke Inlow, _The patent grant_, Baltimore, 1950, p. 33.
[13] _Daily Advertiser_, London, September 23, 1743.

Much less taciturn than Hooper about the composition of his nostrum was
Robert Turlington, who secured a patent in 1744 for "A specifick
balsam, called the balsam of life."[14] The Balsam contained no less
than 27 ingredients, and in his patent specifications Turlington
asserted that it would cure kidney and bladder stones, cholic, and
inward weakness. He shortly issued a 46-page pamphlet in which he
greatly expanded the list.[15] In this appeal to 18th-century
sensibilities, Turlington asserted that the "Author of Nature" has
provided "a Remedy for every Malady." To find them, "Men of Learning
and Genius" have "ransack'd" the "Animal, Mineral and Vegetable World."
His own search had led Turlington to the Balsam, "a perfect Friend to
Nature, which it strengthens and corroborates when weak and declining,
vivifies and enlivens the Spirits, mixes with the Juices and Fluids of
the Body and gently infuses its kindly Influence into those Parts that
are most in Disorder."

Enhanced by Zemanta